Package | us.nlm.vsac |
Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1078.168 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.168/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168 |
Version | 20250122 |
Status | active |
Date | 2025-01-22T01:07:20-05:00 |
Name | Medications_COPD |
Title | medications_COPD |
Realm | us |
Authority | hl7 |
Description | medications_COPD= medications-COPD |
Purpose | (Clinical Focus: COPD drug classes),(Data Element Scope: DRUG_CLASS_MEMBERS: INDICATION: COPD),(Inclusion Criteria: Includes SABA, LABA, SAMA, LAMA, ICS, Roflumilast, Methylxanthines , OCS(Prednisone, Prednisolone), mucolytics, Ensifentrine and Dupillumab),(Exclusion Criteria: Excludes antibiotics like Erythromycin and Azithromycin) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
rxnorm | RxNorm |
ValueSet | |
2.16.840.1.113762.1.4.1078.146 | Long Acting Muscarinic Antagonists (LAMA) |
2.16.840.1.113762.1.4.1078.527 | OCS_Prednisone |
2.16.840.1.113762.1.4.1078.609 | Macrolide_Azithromycin |
2.16.840.1.113762.1.4.1078.719 | OCS_Prednisolone |
2.16.840.1.113762.1.4.1078.72 | Inhaled corticosteroids (IC) |
2.16.840.1.113762.1.4.1078.720 | COPD_Ofloxacin |
2.16.840.1.113762.1.4.1078.721 | COPD_Ciprofloxacin |
2.16.840.1.113762.1.4.1078.722 | COPD_Doxycycline |
2.16.840.1.113762.1.4.1078.976 | Ensifentrine |
2.16.840.1.113762.1.4.1078.977 | Dupilumab |
No narrative content found in resource